Prenatal detection of complex chromosomal aberrations using advanced molecular cytogenetic techniques. 2003

J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
Department of Biomedical Genetics, University Medical Centre, Utrecht, The Netherlands. J.M.dePater@dmg.azu.nl

OBJECTIVE This study aimed to identify a marker chromosome and characterize the short arm of a derivative chromosome 5 in a foetus with the following karyotype: mos 47,XX,del(5)(p?),+i(5)(p10)[50]/48,XX,del(5)(p?),+i(5)(p10),+mar[25]. METHODS Amniocentesis was performed in the 26th week of pregnancy because of ultrasound abnormalities (polyhydramnion and decreased amount of gastric filling). All classic banding techniques were performed. FISH and microdissection combined with reverse painting were used to reveal the exact origin of the marker and any extra material on the deleted chromosome 5p. The parents decided to continue the pregnancy and we compared the clinical features of the child born in week 34 with data from the literature on trisomy 5p. The possible contribution of trisomy of the centromeric region of chromosome 8 and trisomy 8p23.3-->8pter to this clinical picture was evaluated. RESULTS GTG banding showed one normal and two aberrant chromosomes 5 [del(5)(p?) and i(5)(p10)] in all the cells examined. Furthermore, a supernumerary marker chromosome was present in approximately 30% of the cells. The marker was CBG positive and positive with the pancentromere probe, but dystamicinA/DAPI negative. It did not contain NOR-positive satellites. FISH proved this marker to be derived from the centromeric region of chromosome 8. MicroFISH disclosed the aberrant chromosome 5 as der(5)t(5;8)(p10;p23.3). The parent's karyotypes were normal. The baby showed the characteristic features of trisomy 5p syndrome. She died at the age of 15 days after cardiorespiratory arrest. CONCLUSIONS The karyotype was interpreted as mos 47,XX,add(5)(p10).rev ish der(5)t(5;8)(p10;p23.3),+i(5)(p10) (WCP5+,D5S23+)[50]/48,XX,add(5)(p10).rev ish der(5)t(5;8)(p10;p23.3),+i(5)(p10)(WCP5+,D5S23+),+mar.ish 8(p10q10)(D8Z2+,WCP8-)[25]. Therefore, the baby had complete trisomy 5p, with trisomy of the distal part of 8p and of the centromeric region of chromosome 8. The clinical significance of de novo marker chromosomes is a major problem in prenatal counselling. Molecular cytogenetic tools such as FISH and microFISH are indispensable for characterizing markers and determining the breakpoints more precisely in deleted chromosomes.

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011263 Pregnancy Trimester, Third The last third of a human PREGNANCY, from the beginning of the 29th through the 42nd completed week (197 to 294 days) of gestation. Pregnancy, Third Trimester,Trimester, Third,Last Trimester,Last Trimesters,Pregnancies, Third Trimester,Pregnancy Trimesters, Third,Third Pregnancy Trimester,Third Pregnancy Trimesters,Third Trimester,Third Trimester Pregnancies,Third Trimester Pregnancy,Third Trimesters,Trimester, Last,Trimesters, Last,Trimesters, Third
D011296 Prenatal Diagnosis Determination of the nature of a pathological condition or disease in the postimplantation EMBRYO; FETUS; or pregnant female before birth. Diagnosis, Prenatal,Fetal Diagnosis,Fetal Imaging,Fetal Screening,Intrauterine Diagnosis,Antenatal Diagnosis,Antenatal Screening,Diagnosis, Antenatal,Diagnosis, Intrauterine,Prenatal Screening,Antenatal Diagnoses,Antenatal Screenings,Diagnosis, Fetal,Fetal Diagnoses,Fetal Imagings,Fetal Screenings,Imaging, Fetal,Intrauterine Diagnoses,Prenatal Diagnoses,Prenatal Screenings,Screening, Antenatal,Screening, Fetal,Screening, Prenatal
D002895 Chromosomes, Human, Pair 5 One of the two pairs of human chromosomes in the group B class (CHROMOSOMES, HUMAN, 4-5). Chromosome 5
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004933 Esophageal Atresia Congenital abnormality characterized by the lack of full development of the ESOPHAGUS that commonly occurs with TRACHEOESOPHAGEAL FISTULA. Symptoms include excessive SALIVATION; GAGGING; CYANOSIS; and DYSPNEA. Atresia, Esophageal,Atresias, Esophageal,Esophageal Atresias
D005260 Female Females
D005817 Genetic Counseling An educational process that provides information and advice to individuals or families about a genetic condition that may affect them. The purpose is to help individuals make informed decisions about marriage, reproduction, and other health management issues based on information about the genetic disease, the available diagnostic tests, and management programs. Psychosocial support is usually offered. Counseling, Genetic,Genetic Counseling, Prenatal,Prenatal Genetic Counseling
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
May 2007, Prenatal diagnosis,
J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
May 2022, Molecular cytogenetics,
J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
October 2002, Cancer genetics and cytogenetics,
J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
July 2008, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC,
J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
September 2000, Expert reviews in molecular medicine,
J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
January 2003, Journal of applied genetics,
J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
January 2022, Ginekologia polska,
J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
August 2023, Acta obstetricia et gynecologica Scandinavica,
J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
October 1991, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
J M de Pater, and L C P Govaerts, and S A de Man, and C J M van der Sijs-Bos, and G C M L Christiaens, and W M van Dam, and W H Loneus, and J J M Engelen
June 2005, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
Copied contents to your clipboard!